J&J to acquire VC-backed Alios BioPharma for $1.75 bln

Johnson & Johnson has agreed to buy Alios BioPharma for about $1.75 billion in cash.

1 October 2014•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Managers North America US M&A Deals Briefs